GLAUKOS Corp
GKOSNYSECIK 1192448HealthcareFiscal year ends Dec 31
Reports and events: 208 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2817:22 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001193125-26-436400 |
| 2026-10-2816:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-436147 |
| 2026-08-0307:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001192448-26-000002 |
| 2026-07-2917:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-324201 |
| 2026-07-2916:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-323729 |
| 2026-06-0317:12 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-255758 |
| 2026-05-0407:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-202466 |
| 2026-04-3019:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-193004 |
| 2026-04-2916:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-191553 |
| 2026-04-1606:01 ET | DEF 14A | Proxy statementPeriod 2026-05-28 | 0001193125-26-157829 |
| 2026-03-0207:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-021885 |
| 2026-02-2319:54 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-061944 |
| 2026-02-1716:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-016410 |
| 2026-01-1316:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-003321 |
| 2025-11-1007:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-108796 |
| 2025-10-3118:53 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-104529 |
| 2025-10-2916:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-103722 |
| 2025-08-1207:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-011142 |
| 2025-08-0416:56 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010113 |
| 2025-07-3016:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-009798 |
| 2025-06-0316:23 ET | 8-K | 5.07 Shareholder vote results | 0001558370-25-008365 |
| 2025-05-1407:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-007647 |
| 2025-05-0106:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006041 |
| 2025-04-3016:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-005999 |
| 2025-04-1516:30 ET | DEF 14A | Proxy statementPeriod 2025-05-29 | 0001558370-25-004839 |
| 2025-03-1207:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-002745 |
| 2025-02-2518:11 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-001402 |
| 2025-02-2016:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-001217 |
| 2025-01-1416:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-000201 |
| 2024-12-0906:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001558370-24-016082 |
| 2024-12-0306:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-24-015973 |
| 2024-11-1507:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-015776 |
| 2024-11-0517:49 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014295 |
| 2024-11-0416:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-014262 |
| 2024-10-1117:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-013262 |
| 2024-08-0907:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-011675 |
| 2024-08-0216:51 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-010731 |
| 2024-08-0216:44 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-010729 |
| 2024-07-3116:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-010478 |
| 2024-06-2816:47 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events | 0001104659-24-076328 |
| 2024-06-1407:10 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-009169 |
| 2024-06-0507:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-24-008913 |
| 2024-05-2007:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-008440 |
| 2024-05-0317:38 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-006573 |
| 2024-05-0116:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-006383 |
| 2024-04-1617:00 ET | DEF 14A | Proxy statementPeriod 2024-05-30 | 0001558370-24-005203 |
| 2024-02-2807:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-001912 |
| 2024-02-2317:23 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-001630 |
| 2024-02-2116:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-001431 |
| 2024-01-0907:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-000141 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:05 ET. Listed shows no prices and gives no investment advice.